Gary Latham, Ph.D.
Ambion/Asuragen
- IMAT Award: Enzymatic Tools for Degrading Tissue and Preserving RNA (2001)
- Current SBIR Phase II Awardee (2005-2007)
- Impact: Flexible handling of tissue samples while maintaining high performance gene expression analysis
- Patent Pending (application serial number 60/514,313)
- Commercially released by Ambion in February, 2005
|